Walleye Capital’s Innoviva INVA Stock Holding History

Walleye Capital’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100	Closed	-$1K	–	1281
2019 Q4	$1K	Hold	100	–	–	﹤0.01%	1707
2019 Q3	$1K	Buy	+100	New	+$1.2K	﹤0.01%	1839

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital's INVA Position: Q4 2024 in Review

Walleye Capital sold out of Innoviva (INVA) in Q4 2024, closing a stake of 11,066 shares — an estimated $214K sold.

Walleye Capital first reported a position in INVA in Q4 2019 and held it in 4 quarters. The position peaked at $231K in Q1 2023. 235 funds tracked by Wall St. Rank hold INVA as of Q4 2024.

Walleye Capital reported no remaining Innoviva position as of Q4 2024 after selling out during the quarter.
Walleye Capital sold 11,066 Innoviva shares in Q4 2024, an estimated $214K.
Walleye Capital first reported a position in Innoviva in Q4 2019 and held it in 4 quarters.
Walleye Capital's Innoviva position peaked at $231K in Q1 2023.
235 funds tracked by Wall St. Rank held Innoviva as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.